Article 2: From PCOS to PMOS
Why in News: A global medical consensus published in The Lancet has renamed Polycystic Ovary Syndrome (PCOS) as Poly-endocrine Metabolic Ovarian Syndrome (PMOS) to better reflect the disorder’s endocrine, metabolic, and reproductive dimensions. India played an important role in this international consultation process.
Key Details
- PCOS has been renamed PMOS after nearly 14 years of global scientific consultations involving clinicians, researchers, and patient groups. The new term recognises that the condition is not limited to ovarian cysts but affects multiple body systems.
- The renaming exercise involved more than 22,000 survey responses, workshops, and consultations with women affected by the disorder. This reflects an evidence-based and patient-centric approach towards global health governance.
- India actively contributed to the consensus-building process through reproductive health experts and medical associations. The issue holds special relevance because India has a high prevalence of the disorder among women.
- Experts believe the new terminology will improve diagnosis, awareness, treatment, and public understanding of the condition. It is expected to reduce misconceptions associated with the earlier term “polycystic ovaries”.
What is PMOS?
- Poly-endocrine Metabolic Ovarian Syndrome (PMOS) is a complex hormonal and metabolic disorder affecting women of reproductive age. It impacts ovarian function, hormone regulation, insulin metabolism, and overall reproductive health.
- The condition is associated with irregular menstruation, infertility, obesity, acne, excessive hair growth, and insulin resistance. Long-term complications include Type-2 diabetes, cardiovascular diseases, anxiety, and depression.
- PMOS affects nearly one in eight women globally, according to international estimates. In India, prevalence studies suggest incidence rates ranging between 16% and 18% among women.
- The disorder often begins during adolescence but may remain undiagnosed for several years. Delayed diagnosis increases risks of metabolic complications and mental health challenges.
Why Was PCOS Renamed?
- The term “Polycystic Ovary Syndrome” was considered scientifically misleading. Many women diagnosed with the condition do not actually have ovarian cysts in the pathological sense.
- In PMOS, immature follicles fail to develop fully and remain arrested midway during ovulation. On ultrasound, these follicles appear as small fluid-filled structures that were historically mistaken as cysts.
- The earlier terminology overemphasised ovarian symptoms while ignoring metabolic and endocrine complications. This often resulted in incomplete treatment approaches focused only on fertility concerns.
- The new term highlights the broader systemic nature of the disorder involving hormones, metabolism, and reproductive health. It promotes holistic diagnosis and integrated medical management.
Endocrine System and Hormonal Imbalance
- The endocrine system consists of glands that produce hormones regulating growth, metabolism, and reproduction. In PMOS, hormonal imbalance disrupts normal ovulation and menstrual cycles.
- The disorder involves dysfunction in the hypothalamus-pituitary-ovarian axis. This alters secretion of reproductive hormones and affects ovarian follicle development.
- Insulin resistance is a major feature of PMOS and contributes to elevated androgen levels. High androgen levels lead to symptoms such as acne, excessive facial hair, and irregular periods.
- The condition also affects pancreatic function, adipose tissue metabolism, and inflammatory pathways. This explains its strong association with obesity and metabolic syndrome.
Metabolic Syndrome and India’s Health Burden
- Metabolic syndrome refers to a cluster of conditions including obesity, hypertension, insulin resistance, and abnormal cholesterol levels. It significantly increases the risk of diabetes and cardiovascular diseases.
- India already faces a rising burden of diabetes and obesity due to rapid urbanisation and lifestyle changes. The inclusion of “metabolic” in PMOS is particularly relevant in the Indian context.
- Experts link higher susceptibility among South Asians to the “thrifty genotype hypothesis.” This theory suggests populations historically exposed to food scarcity evolved to store fat more efficiently.
- In modern calorie-rich environments, this adaptation increases vulnerability to obesity and diabetes. This partly explains the growing prevalence of metabolic disorders in India.
Women’s Health and Public Health Concerns
- PMOS is not merely a reproductive disorder but also a major public health issue. It affects physical health, mental well-being, fertility, and quality of life.
- Mental health complications such as anxiety, depression, and low self-esteem are commonly reported among affected women. Social stigma and lack of awareness often worsen psychological distress.
- Early diagnosis and lifestyle interventions can significantly improve long-term outcomes. Regular exercise, balanced nutrition, and stress management remain important preventive strategies.
- Public awareness regarding menstrual and reproductive health remains limited in many parts of India. This contributes to delayed consultation and underreporting of symptoms.
India’s Healthcare Response and Challenges
- India has expanded focus on women’s healthcare through programmes related to reproductive and adolescent health. However, awareness and screening for hormonal disorders remain inadequate.
- Access to endocrinologists, nutrition counselling, and mental healthcare is uneven across rural and urban regions. This creates disparities in diagnosis and treatment outcomes.
- The growing burden of lifestyle diseases requires integration of reproductive health with metabolic healthcare services. A multidisciplinary approach involving gynaecologists, endocrinologists, and mental health experts is necessary.
- Medical education and public health campaigns must incorporate updated understanding of PMOS. This will help reduce stigma and improve healthcare accessibility.
Global Health Governance and Medical Consensus
- The renaming of PCOS reflects the importance of evidence-based global medical collaboration. It demonstrates how scientific terminology evolves with advancing medical knowledge.
- International organisations, researchers, and patient advocacy groups played an important role in the consensus process. This participatory approach improves credibility and acceptance of healthcare reforms.
- The move also aligns with broader efforts to adopt patient-sensitive and scientifically accurate medical terminology. Such reforms help improve communication between doctors and patients.
- India’s participation highlights its growing role in global health research and reproductive medicine. It also reflects the importance of South Asian perspectives in international health discussions.
Way Forward
- Strengthening Awareness: Large-scale awareness campaigns are needed on menstrual, reproductive, and metabolic health. Early recognition of symptoms can reduce complications and improve treatment outcomes.
- Integrated Healthcare: Reproductive, endocrine, and mental health services should be linked together. A holistic approach is essential for effective management of PMOS.
- Lifestyle Interventions: Promoting healthy diets, physical activity, and preventive healthcare is crucial. This can help reduce obesity and insulin resistance among adolescents and women.
- Research and Data: India needs stronger epidemiological research on hormonal and metabolic disorders. Better data will support targeted public health interventions and policy planning.
Conclusion
The transition from PCOS to PMOS represents more than a change in terminology; it reflects a deeper scientific understanding of women’s health. Recognising the metabolic, endocrine, and psychological dimensions of the disorder can improve diagnosis, reduce stigma, and ensure comprehensive treatment. For India, where lifestyle diseases are rising rapidly, addressing PMOS through awareness, preventive healthcare, and integrated medical systems will be critical for improving women’s health outcomes.
EXPECTED QUESTION FOR UPSC CSE
Prelims MCQ
Q. With reference to Poly-endocrine Metabolic Ovarian Syndrome (PMOS), consider the following statements:
- PMOS is only a reproductive disorder affecting ovarian function.
- Insulin resistance is commonly associated with PMOS.
- The condition may increase the risk of Type-2 diabetes and cardiovascular diseases.
How many of the above statements are correct?
(a) Only one
(b) Only two
(c) All three
(d) None
Answer: (b)